Literature DB >> 9023998

Thermal resistance of Enterobacter sakazakii in reconstituted dried-infant formula.

M Nazarowec-White1, J M Farber.   

Abstract

Enterobacter sakazakii, designated a unique species in 1980, has been implicated in a rare but severe form of neonatal meningitis, with dried-infant formula being implicated as the mode of transmission. The high mortality rate (40-80%) and the lack of information about this organism led to a study of the heat resistance of Ent. sakazakii in reconstituted dried-infant formula. Ten Canadian Ent. sakazakii strains (5 clinical and 5 food isolates) were used to determine the heat resistance of this organism at 52, 54, 56, 58 and 60 degrees C in reconstituted dried-infant formula. D-values of 54.8, 23.7, 10.3, 4.2 and 2.5 min were obtained for each temperature, respectively. The overall calculated z-value was 5.82 degrees C. In a comparison of the D-values of several members of the Enterobacteriaceae in dairy products, Ent. sakazakii appeared to be one of the most thermotolerant organisms. The importance of process control during manufacture and the use of aseptic procedures during the preparation, use and storage of dried-infant formula is discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9023998     DOI: 10.1046/j.1472-765x.1997.00328.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  17 in total

1.  Powdered infant formula and fatal infection with Enterobacter sakazakii.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2002-06-11       Impact factor: 8.262

Review 2.  Enterobacter sakazakii and other bacteria in powdered infant milk formula.

Authors:  Stephen J Forsythe
Journal:  Matern Child Nutr       Date:  2005-01       Impact factor: 3.092

3.  Performance of media for recovering stressed cells of Enterobacter sakazakii as determined using spiral plating and ecometric techniques.

Authors:  J B Gurtler; L R Beuchat
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

4.  Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula.

Authors:  J van Acker; F de Smet; G Muyldermans; A Bougatef; A Naessens; S Lauwers
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Daqu Fermentation Selects for Heat-Resistant Enterobacteriaceae and Bacilli.

Authors:  Zhiying Wang; Pan Li; Lixin Luo; David J Simpson; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2018-10-17       Impact factor: 4.792

6.  Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction.

Authors:  Kwang-Pyo Kim; Martin J Loessner
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

Review 7.  Enterobacter sakazakii: an emerging pathogen in infants and neonates.

Authors:  Catherine J Hunter; Mikael Petrosyan; Henri R Ford; Nemani V Prasadarao
Journal:  Surg Infect (Larchmt)       Date:  2008-10       Impact factor: 2.150

8.  Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026.

Authors:  M Hayes; R P Ross; G F Fitzgerald; C Hill; C Stanton
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

9.  Isolation of Cronobacter spp. (formerly Enterobacter sakazakii) from infant food, herbs and environmental samples and the subsequent identification and confirmation of the isolates using biochemical, chromogenic assays, PCR and 16S rRNA sequencing.

Authors:  Ziad W Jaradat; Qotaiba O Ababneh; Ismail M Saadoun; Nawal A Samara; Abrar M Rashdan
Journal:  BMC Microbiol       Date:  2009-10-27       Impact factor: 3.605

10.  Pan-genome analysis of the emerging foodborne pathogen Cronobacter spp. suggests a species-level bidirectional divergence driven by niche adaptation.

Authors:  Christopher J Grim; Michael L Kotewicz; Karen A Power; Gopal Gopinath; Augusto A Franco; Karen G Jarvis; Qiong Q Yan; Scott A Jackson; Venugopal Sathyamoorthy; Lan Hu; Franco Pagotto; Carol Iversen; Angelika Lehner; Roger Stephan; Séamus Fanning; Ben D Tall
Journal:  BMC Genomics       Date:  2013-05-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.